BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37402976)

  • 1. Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial.
    Nguyen CL; Zhou M; Easwaralingam N; Seah JL; Azimi F; Mak C; Pulitano C; Warrier S
    Ann Surg Oncol; 2023 Oct; 30(11):6520-6527. PubMed ID: 37402976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis.
    Thongvitokomarn S; Polchai N
    Asian Pac J Cancer Prev; 2020 May; 21(5):1187-1195. PubMed ID: 32458621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer.
    Fujisawa Y; Nakamura Y; Kawachi Y; Otsuka F
    J Surg Oncol; 2012 Jul; 106(1):41-5. PubMed ID: 22252373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
    Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
    World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery.
    Kedrzycki MS; Leiloglou M; Ashrafian H; Jiwa N; Thiruchelvam PTR; Elson DS; Leff DR
    Ann Surg Oncol; 2021 Jul; 28(7):3738-3748. PubMed ID: 33156466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study.
    Coufal O; Fait V
    World J Surg Oncol; 2016 Dec; 14(1):299. PubMed ID: 27905950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
    Somashekhar SP; Kumar CR; Ashwin KR; Zaveri SS; Jampani A; Ramya Y; Parameswaran R; Rakshit S
    Clin Breast Cancer; 2020 Oct; 20(5):e576-e583. PubMed ID: 32389561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
    Jung SY; Han JH; Park SJ; Lee EG; Kwak J; Kim SH; Lee MH; Lee ES; Kang HS; Lee KS; Park IH; Sim SH; Jeong HJ; Kwon Y; Lee DE; Kim SK; Lee S
    Ann Surg Oncol; 2019 Aug; 26(8):2409-2416. PubMed ID: 31065958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Study Evaluating the Accuracy of Indocyanine Green (ICG) Fluorescence Compared with Radioisotope for Sentinel Lymph Node (SLN) Detection in Early Breast Cancer.
    Dumitru D; Ghanakumar S; Provenzano E; Benson JR
    Ann Surg Oncol; 2022 May; 29(5):3014-3020. PubMed ID: 35000084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer.
    Hua B; Li Y; Yang X; Ren X; Lu X
    World J Surg Oncol; 2022 Aug; 20(1):253. PubMed ID: 35941602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.
    Jung SY; Kim SK; Kim SW; Kwon Y; Lee ES; Kang HS; Ko KL; Shin KH; Lee KS; Park IH; Ro J; Jeong HJ; Joo J; Kang SH; Lee S
    Ann Surg Oncol; 2014 Apr; 21(4):1254-9. PubMed ID: 24356798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Indocyanine Green Fluorescence-Guided Video-Assisted Technique for Sentinel Node Biopsy in Breast Cancer.
    Sorrentino L; Sartani A; Pietropaolo G; Bossi D; Mazzucchelli S; Truffi M; Foschi D; Corsi F
    World J Surg; 2018 Sep; 42(9):2815-2824. PubMed ID: 29404755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye.
    Buda A; Papadia A; Di Martino G; Imboden S; Bussi B; Guerra L; De Ponti E; Reato C; Gasparri ML; Crivellaro C; Mueller M
    J Minim Invasive Gynecol; 2018; 25(3):455-460. PubMed ID: 29032256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New techniques versus standard mapping for sentinel lymph node biopsy in breast cancer: a systematic review and meta-analysis.
    Rocco N; Velotti N; Pontillo M; Vitiello A; Berardi G; Accurso A; Masone S; Musella M
    Updates Surg; 2023 Sep; 75(6):1699-1710. PubMed ID: 37326934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer.
    Sugie T; Kinoshita T; Masuda N; Sawada T; Yamauchi A; Kuroi K; Taguchi T; Bando H; Yamashiro H; Lee T; Shinkura N; Kato H; Ikeda T; Yoshimura K; Ueyama H; Toi M
    Ann Surg Oncol; 2016 Jan; 23(1):44-50. PubMed ID: 26275781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
    Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A
    Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer.
    Takemoto N; Koyanagi A; Yasuda M; Yamamoto H
    BMC Womens Health; 2018 Sep; 18(1):151. PubMed ID: 30227837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indocyanine Green and Methylene Blue Dye Guided Sentinel Lymph Node Biopsy in Early Breast Cancer: A Single-Center Retrospective Survival Study in 1574 Patients.
    Yang R; Dong C; Jiang T; Zhang X; Zhang F; Fan Z
    Clin Breast Cancer; 2023 Jun; 23(4):408-414. PubMed ID: 36907808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near Infrared Fluorescent Lymph Node Mapping with Indocyanine Green in Breast Cancer Patients: A Prospective Trial.
    Valente SA; Al-Hilli Z; Radford DM; Yanda C; Tu C; Grobmyer SR
    J Am Coll Surg; 2019 Apr; 228(4):672-678. PubMed ID: 30582975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.